WuXi AppTec Co Ltd Total Liabilities
WuXi AppTec Co Ltd total liabilities. Based on the latest financial reports, WuXi AppTec Co Ltd (603259) has total liabilities worth CN¥23.41 Billion CNY (≈ $3.43 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603259 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of WuXi AppTec Co Ltd (2014–2024)
Total liabilities of WuXi AppTec Co Ltd from 2014 to 2024. This chart illustrates how WuXi AppTec Co Ltd's total liabilities have evolved over time, based on quarterly financial data.
WuXi AppTec Co Ltd Competitors by Total Liabilities
The table below lists competitors of WuXi AppTec Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
L3Harris Technologies Inc
NYSE:LHX
|
USA | $22.09 Billion |
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $3.14 Billion |
|
Constellation Software Inc.
TO:CSU
|
Canada | CA$11.22 Billion |
|
Deutsche Bank Aktiengesellschaft
F:DBK
|
Germany | €1.40 Trillion |
|
Thales S.A.
PA:HO
|
France | €31.72 Billion |
|
ASE Industrial Holding Co Ltd ADR
NYSE:ASX
|
USA | $515.97 Billion |
|
Electronic Arts Inc
NASDAQ:EA
|
USA | $6.37 Billion |
|
NAURA Technology Group Co Ltd
SHE:002371
|
China | CN¥45.54 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down WuXi AppTec Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see WuXi AppTec Co Ltd total assets.
Liquidity & Leverage Metrics
WuXi AppTec Co Ltd Total Liabilities Ratios Explained
WuXi AppTec Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how WuXi AppTec Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for WuXi AppTec Co Ltd (2014–2024)
The table below shows the annual total liabilities of WuXi AppTec Co Ltd from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥21.24 Billion ≈ $3.11 Billion |
+17.01% |
| 2023-12-31 | CN¥18.15 Billion ≈ $2.66 Billion |
+2.19% |
| 2022-12-31 | CN¥17.76 Billion ≈ $2.60 Billion |
+8.51% |
| 2021-12-31 | CN¥16.37 Billion ≈ $2.40 Billion |
+20.61% |
| 2020-12-31 | CN¥13.57 Billion ≈ $1.99 Billion |
+14.74% |
| 2019-12-31 | CN¥11.83 Billion ≈ $1.73 Billion |
+162.76% |
| 2018-12-31 | CN¥4.50 Billion ≈ $658.78 Million |
-22.94% |
| 2017-12-31 | CN¥5.84 Billion ≈ $854.93 Million |
+29.02% |
| 2016-12-31 | CN¥4.53 Billion ≈ $662.63 Million |
+39.06% |
| 2015-12-31 | CN¥3.26 Billion ≈ $476.50 Million |
+22.44% |
| 2014-12-31 | CN¥2.66 Billion ≈ $389.18 Million |
-- |
About WuXi AppTec Co Ltd
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manuf… Read more